| Product Code: ETC12022512 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of Duchenne Muscular Dystrophy (DMD) drugs to Togo in 2024 continued to be dominated by top exporting countries such as France, India, China, USA, and Denmark. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a negative Compound Annual Growth Rate (CAGR) of -2.47% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024, at -8.58%. This suggests a challenging landscape for DMD drug imports to Togo, possibly influenced by various factors impacting the market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Duchenne Muscular Dystrophy DMD Drugs Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Togo Duchenne Muscular Dystrophy DMD Drugs Market - Industry Life Cycle |
3.4 Togo Duchenne Muscular Dystrophy DMD Drugs Market - Porter's Five Forces |
3.5 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Togo Duchenne Muscular Dystrophy DMD Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Togo Duchenne Muscular Dystrophy DMD Drugs Market Trends |
6 Togo Duchenne Muscular Dystrophy DMD Drugs Market, By Types |
6.1 Togo Duchenne Muscular Dystrophy DMD Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.4 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Exon Skipping Drugs, 2021 - 2031F |
6.1.5 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.6 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Anti-Inflammatory Drugs, 2021 - 2031F |
6.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.5 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.3 Togo Duchenne Muscular Dystrophy DMD Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.3.5 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 Togo Duchenne Muscular Dystrophy DMD Drugs Market Import-Export Trade Statistics |
7.1 Togo Duchenne Muscular Dystrophy DMD Drugs Market Export to Major Countries |
7.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Imports from Major Countries |
8 Togo Duchenne Muscular Dystrophy DMD Drugs Market Key Performance Indicators |
9 Togo Duchenne Muscular Dystrophy DMD Drugs Market - Opportunity Assessment |
9.1 Togo Duchenne Muscular Dystrophy DMD Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Togo Duchenne Muscular Dystrophy DMD Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Togo Duchenne Muscular Dystrophy DMD Drugs Market - Competitive Landscape |
10.1 Togo Duchenne Muscular Dystrophy DMD Drugs Market Revenue Share, By Companies, 2024 |
10.2 Togo Duchenne Muscular Dystrophy DMD Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |